Table of Content

Table of Contents
1 RESEARCH SCOPE
1.1 Research Product Definition
1.2 Research Segmentation
1.2.1 Product Type
1.2.2 Main product Type of Major Players
1.3 Demand Overview
1.4 Research Methodology
2 GLOBAL COMPANION ANIMAL SPECIALTY DRUGS INDUSTRY
2.1 Summary about Companion Animal Specialty Drugs Industry
2.2 Companion Animal Specialty Drugs Market Trends
2.2.1 Companion Animal Specialty Drugs Production & Consumption Trends
2.2.2 Companion Animal Specialty Drugs Demand Structure Trends
2.3 Companion Animal Specialty Drugs Cost & Price
3 MARKET DYNAMICS
3.1 Manufacturing & Purchasing Behavior in 2020
3.2 Market Development under the Impact of COVID-19
3.2.1 Drivers
3.2.2 Restraints
3.2.3 Opportunity
3.2.4 Risk
4 GLOBAL MARKET SEGMENTATION
4.1 Region Segmentation (2017 to 2021f)
4.1.1 North America (U.S., Canada and Mexico)
4.1.2 Europe (Germany, UK, France, Italy, Rest of Europe)
4.1.3 Asia-Pacific (China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific)
4.1.4 South America (Brazil,, Argentina, Rest of Latin America)
4.1.5 Middle East and Africa (GCC, North Africa, South Africa, Rest of Middle East and Africa)
4.2 Product Type Segmentation (2017 to 2021f)
4.2.1 Vaccines
4.2.2 Antibiotics
4.2.3 Parasiticides
4.2.4 Feed Additives
4.2.5 Others
4.3 Consumption Segmentation (2017 to 2021f)
4.3.1 Veterinary Hospitals
4.3.2 Pet Care Clinics
4.3.3 Pharmacy Stores
5 NORTH AMERICA MARKET SEGMENT
5.1 Region Segmentation (2017 to 2021f)
5.1.1 U.S.
5.1.2 Canada
5.1.3 Mexico
5.2 Product Type Segmentation (2017 to 2021f)
5.2.1 Vaccines
5.2.2 Antibiotics
5.2.3 Parasiticides
5.2.4 Feed Additives
5.2.5 Others
5.3 Consumption Segmentation (2017 to 2021f)
5.3.1 Veterinary Hospitals
5.3.2 Pet Care Clinics
5.3.3 Pharmacy Stores
5.4 Impact of COVID-19 in North America
6 EUROPE MARKET SEGMENTATION
6.1 Region Segmentation (2017 to 2021f)
6.1.1 Germany
6.1.2 UK
6.1.3 France
6.1.4 Italy
6.1.5 Rest of Europe
6.2 Product Type Segmentation (2017 to 2021f)
6.2.1 Vaccines
6.2.2 Antibiotics
6.2.3 Parasiticides
6.2.4 Feed Additives
6.2.5 Others
6.3 Consumption Segmentation (2017 to 2021f)
6.3.1 Veterinary Hospitals
6.3.2 Pet Care Clinics
6.3.3 Pharmacy Stores
6.4 Impact of COVID-19 in Europe
7 ASIA-PACIFIC MARKET SEGMENTATION
7.1 Region Segmentation (2017 to 2021f)
7.1.1 China
7.1.2 India
7.1.3 Japan
7.1.4 South Korea
7.1.5 Southeast Asia
7.1.6 Australia
7.1.7 Rest of Asia Pacific
7.2 Product Type Segmentation (2017 to 2021f)
7.2.1 Vaccines
7.2.2 Antibiotics
7.2.3 Parasiticides
7.2.4 Feed Additives
7.2.5 Others
7.3 Consumption Segmentation (2017 to 2021f)
7.3.1 Veterinary Hospitals
7.3.2 Pet Care Clinics
7.3.3 Pharmacy Stores
7.4 Impact of COVID-19 in Europe
8 SOUTH AMERICA MARKET SEGMENTATION
8.1 Region Segmentation (2017 to 2021f)
8.1.1 Brazil
8.1.2 Argentina
8.1.3 Rest of Latin America
8.2 Product Type Segmentation (2017 to 2021f)
8.2.1 Vaccines
8.2.2 Antibiotics
8.2.3 Parasiticides
8.2.4 Feed Additives
8.2.5 Others
8.3 Consumption Segmentation (2017 to 2021f)
8.3.1 Veterinary Hospitals
8.3.2 Pet Care Clinics
8.3.3 Pharmacy Stores
8.4 Impact of COVID-19 in Europe
9 MIDDLE EAST AND AFRICA MARKET SEGMENTATION
9.1 Region Segmentation (2017 to 2021f)
9.1.1 GCC
9.1.2 North Africa
9.1.3 South Africa
9.1.4 Rest of Middle East and Africa
9.2 Product Type Segmentation (2017 to 2021f)
9.2.1 Vaccines
9.2.2 Antibiotics
9.2.3 Parasiticides
9.2.4 Feed Additives
9.2.5 Others
9.3 Consumption Segmentation (2017 to 2021f)
9.3.1 Veterinary Hospitals
9.3.2 Pet Care Clinics
9.3.3 Pharmacy Stores
9.4 Impact of COVID-19 in Europe
10 COMPETITION OF MAJOR PLAYERS
10.1 Brief Introduction of Major Players
10.1.1 Bayer
10.1.2 Elanco
10.1.3 Merial
10.1.4 Zoetis
10.1.5 Aratana therapeutics
10.1.6 Beaphar
10.1.7 Henry Schein
10.1.8 Mars
10.1.9 The J.M Smucker Company
10.2 Companion Animal Specialty Drugs Sales Date of Major Players (2017-2020e)
10.2.1 Bayer
10.2.2 Elanco
10.2.3 Merial
10.2.4 Zoetis
10.2.5 Aratana therapeutics
10.2.6 Beaphar
10.2.7 Henry Schein
10.2.8 Mars
10.2.9 The J.M Smucker Company
10.3 Market Distribution of Major Players
10.4 Global Competition Segmentation
11 MARKET FORECAST
11.1 Forecast by Region
11.2 Forecast by Demand
11.3 Environment Forecast
11.3.1 Impact of COVID-19
11.3.2 Geopolitics Overview
11.3.3 Economic Overview of Major Countries
12 REPORT SUMMARY STATEMENT

List of Figure

List of Table
Table Companion Animal Specialty Drugs Product Type Overview
Table Companion Animal Specialty Drugs Product Type Market Share List
Table Companion Animal Specialty Drugs Product Type of Major Players
Table Brief Introduction of Bayer
Table Brief Introduction of Elanco
Table Brief Introduction of Merial
Table Brief Introduction of Zoetis
Table Brief Introduction of Aratana therapeutics
Table Brief Introduction of Beaphar
Table Brief Introduction of Henry Schein
Table Brief Introduction of Mars
Table Brief Introduction of The J.M Smucker Company
Table Products & Services of Bayer
Table Products & Services of Elanco
Table Products & Services of Merial
Table Products & Services of Zoetis
Table Products & Services of Aratana therapeutics
Table Products & Services of Beaphar
Table Products & Services of Henry Schein
Table Products & Services of Mars
Table Products & Services of The J.M Smucker Company
Table Market Distribution of Major Players
Table Global Major Players Sales Revenue (Million USD) 2017-2020e
Table Global Major Players Sales Revenue (Million USD) Share 2017-2020e
Table Global Companion Animal Specialty Drugs Market Forecast (Million USD) by Region 2021f-2026f
Table Global Companion Animal Specialty Drugs Market Forecast (Million USD) Share by Region 2021f-2026f
Table Global Companion Animal Specialty Drugs Market Forecast (Million USD) by Demand 2021f-2026f
Table Global Companion Animal Specialty Drugs Market Forecast (Million USD) Share by Demand 2021f-2026f